80 related articles for article (PubMed ID: 11770313)
1. [The activity of cathepsin B in colorectal adenocarcinomas].
Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Sulkowski S; Chrzanowska A
Pol Merkur Lekarski; 2001 Oct; 11(64):330-3. PubMed ID: 11770313
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin D activity in colorectal cancer.
Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Zalewski B; Gnojnicki I; Kisielewski W
Rocz Akad Med Bialymst; 2001; 46():38-46. PubMed ID: 11780577
[TBL] [Abstract][Full Text] [Related]
3. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.
Guzińska-Ustymowicz K; Zalewski B; Kasacka I; Piotrowski Z; Skrzydlewska E
Anticancer Res; 2004; 24(5A):2847-51. PubMed ID: 15517887
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
Chabowski A; Sulkowska M; Sulkowski M; Famulski W; Skrzydlewska E; Kisielewski W
Folia Histochem Cytobiol; 2001; 39(2):153-4. PubMed ID: 11374801
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin D expression in human colorectal cancer: relationship with tumour type and tissue differentiation grade.
Sebzda T; Saleh Y; Gburek J; Andrzejak R; Gnus J; Siewinski M; Grzebieniak Z
J Exp Ther Oncol; 2005; 5(2):145-50. PubMed ID: 16471040
[TBL] [Abstract][Full Text] [Related]
6. MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC).
Guzińska-Ustymowicz K
Anticancer Res; 2006; 26(2B):1589-94. PubMed ID: 16619576
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma.
Kruszewski WJ; Rzepko R; Wojtacki J; Skokowski J; Kopacz A; Jaśkiewicz K; Drucis K
Neoplasma; 2004; 51(1):38-43. PubMed ID: 15004658
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
Talieri M; Papadopoulou S; Scorilas A; Xynopoulos D; Arnogianaki N; Plataniotis G; Yotis J; Agnanti N
Cancer Lett; 2004 Mar; 205(1):97-106. PubMed ID: 15036666
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
[TBL] [Abstract][Full Text] [Related]
10. 5-Lipoxygenase is coexpressed with Cox-2 in sporadic colorectal cancer: a correlation with advanced stage.
Barresi V; Grosso M; Vitarelli E; Tuccari G; Barresi G
Dis Colon Rectum; 2007 Oct; 50(10):1576-84. PubMed ID: 17762961
[TBL] [Abstract][Full Text] [Related]
11. [Expression of cathepsin B and its clinical importance in colorectal cancer].
Yu B; Li SY; An P; Zuo FY; Cai HY
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):507-9. PubMed ID: 16299652
[TBL] [Abstract][Full Text] [Related]
12. Detection of alkaline sphingomyelinase activity in human stool: proposed role as a new diagnostic and prognostic marker of colorectal cancer.
Di Marzio L; Di Leo A; Cinque B; Fanini D; Agnifili A; Berloco P; Linsalata M; Lorusso D; Barone M; De Simone C; Cifone MG
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):856-62. PubMed ID: 15824156
[TBL] [Abstract][Full Text] [Related]
13. Increased cathepsin B activity in human lung tumors.
Krepela E; Kasafírek E; Novák K; Viklický J
Neoplasma; 1990; 37(1):61-70. PubMed ID: 2320181
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin B in the growth of colorectal cancer: increased activity of cathepsin B in human colorectal cancer.
Satoh Y; Higashi T; Nouso K; Shiota T; Kinugasa N; Yoshida K; Uematsu S; Nakatsukasa H; Nishimura Y; Tsuji T
Acta Med Okayama; 1996 Dec; 50(6):305-11. PubMed ID: 8985467
[TBL] [Abstract][Full Text] [Related]
15. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
16. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
[TBL] [Abstract][Full Text] [Related]
17. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D.
van der Stappen JW; Williams AC; Maciewicz RA; Paraskeva C
Int J Cancer; 1996 Aug; 67(4):547-54. PubMed ID: 8759615
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker.
Devetzi M; Scorilas A; Tsiambas E; Sameni M; Fotiou S; Sloane BF; Talieri M
Gynecol Oncol; 2009 Mar; 112(3):531-6. PubMed ID: 19110306
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin and erythropoietin receptor in colorectal cancer.
Chabowska AM; Sulkowska M; Chabowski A; Wincewicz A; Koda M; Sulkowski S
Int J Surg Pathol; 2008 Jul; 16(3):269-76. PubMed ID: 18487221
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between clinical pathologic factors and enzymatic activity of orotate Phosphoribosyl transferase (OPRT), Dihydropyrimidine dehydrogenase (DPD) and Thymidylate synthase (TS) in colorectal cancer].
Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Kanazawa Y; Shirakawa T; Ohkawa K; Koizumi M; Ohaki Y; Yamashita K; Tajiri T
Gan To Kagaku Ryoho; 2006 Jun; 33(6):789-93. PubMed ID: 16770098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
